Search PubMed⌕ Search

Biomedical subjects

M Ueki

Publications and source records attributed to M Ueki.

At least 127 records · Page 7Linked to original sources
PubMed1995

The amelioration of hyperglycemia in streptozotocin-induced diabetic rats after the intraportal transplantation of an insufficient number of islets by nicotinamide treatment.

The purpose of the present study was to determine whether or not hyperglycemia in streptozotocin (STZ)-induced diabetic rats after the intraportal transplantation of an insufficient number of isogenic islets can be ameliorated by nicotinamide treatment. WKA/Qdj (RT 1u) rats were used both as donors and recipients. Islets were isolated by the collagenase technique. A total of 350 islets was transplanted into the liver via the portal vein of the STZ-induced diabetic rats. Either nicotinamide (NA, 0.5 g/kg) or a vehicle (saline) was administered ip once a day for 60 days after transplantation. All the diabetic rats without islet transplantation remained hyperglycemic irrespective of the NA treatment. All the recipients (n = 12) bearing the islet grafts and treated with saline remained hyperglycemic (> 400 mg/dl) at 60 days after transplantation. In marked contrast, all the recipients (n = 18) with islet grafts and treated with NA became normoglycemic (< 200 mg/dl) at 16.2 +/- 7.1 days (mean +/- SD) after transplantation. Morphologically, islets were easily found in the liver of the recipients. Aldehyde-fuchsin stain revealed that the beta cells in the islet grafts of the NA treated recipients were well granulated, whereas those treated with saline were degranulated. The insulin content of the liver bearing the grafts treated with either NA or saline was 116.3 +/- 26.0 micrograms/liver (n = 4) or 5.7 +/- 2.2 micrograms (n = 4), respectively, while that of 350 donor islets was 29.4 +/- 2.5 micrograms (n = 5). The insulin content of the pancreas in the NA- or saline-treated recipients was 27.3 +/- 10.6 micrograms/pancreas (n = 4) or 2.7 +/- 1.2 micrograms (n = 4), respectively, while those of the pancreas from the diabetic rats without transplantation was 1.9 +/- 0.7 micrograms (n = 4) or 1.6 +/- 0.8 micrograms (n = 5), respectively. These findings clearly demonstrate that the hyperglycemia in the STZ-diabetic recipients after transplantation of an insufficient number of islets can be ameliorated while, in addition, the islet mass in the liver as well as the endogenous pancreas both increase in size with nicotinamide treatment.

Animals↗
PubMed1995

Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography-tandem mass spectrometry.

1-Phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline were detected for the first time in parkinsonian human brain using gas chromatography-tandem mass spectrometry (GC-MS-MS). Since these compounds are structural analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that produces parkinsonism in humans, they might be candidates for endogenous MPTP-like neurotoxins.

Aged↗
PubMed1995

[Effects of ulinastatin on renal function after subrenal aortic cross-clamping].

Ten patients who had undergone temporary occlusion of the abdominal aorta below the origin of the renal arteries were studied to evaluate the effect of ulinastatin on the postoperative renal function after abdominal aortic cross-clamping. They were divided into two groups: ulinastatin group (ulinastatin 300,000 units.day-1 during intraoperative and postoperative three days, N = 5), control group (N = 5). In ulinastatin group, the increase of N-acetyl-beta-D-glucosaminidase on the third postoperative day was inhibited and renal function was well maintained. These results suggest that the administration of ulinastatin in perioperative day prevents postoperative renal dysfunction after abdominal aortic cross-clamping.

Acetylglucosaminidase↗
PubMed1995

[A case of beneficial effect of ulinastatin on postoperative renal function in a patient with acute renal failure].

We experienced a case in which ulinastatin may have been beneficial to improve postoperative renal function in a patient with acute renal failure. The patient had acute renal failure with serum Cr of 9.3 mg.dl-1 after nephrectomy. On the 14th postoperative day, he underwent laparotomy under diagnosis of ileus. Administration of ulinastatin, 300,000 units.day-1 for 4 days, increased urine volume and creatine clearance and improved serum Cr level. This case suggests that ulinastatin might exert a beneficial effect on the recovery from renal tubular damage and on the glomerular filtration ratio, with resultant improvement of acute renal failure.

Acute Kidney Injury↗
PubMed1995

Efficacy of ipriflavone and 1 alpha vitamin D therapy for the cessation of vertebral bone loss.

OBJECTIVE: This study investigated whether a combined regimen of ipriflavone and 1 alpha vitamin D is effective in stopping postmenopausal bone loss. METHODS: Ninety-eight postmenopausal women were recruited and randomly assigned to one of four groups: group 1, ipriflavone alone; group 2, 1 alpha vitamin D alone; group 3, combined regimen of ipriflavone and 1 alpha vitamin D; group 4, no treatment. Vertebral bone mineral density, measured by dual energy X-ray absorptiometry, serum alkaline phosphatase, calcitonin, parathyroid hormone, osteocalcin, urinary calcium and hydroxyproline were measured before and at the 6th, 12th and 18th month of the study. All comparisons were made using Student's t-test of means. RESULT: There was a significant reduction in vertebral bone loss in the patients receiving the combined therapy (mean loss after 18 months 0.33% in the combination group vs. 2.37%, 1.15% and 3.70% in the ipriflavone alone, 1 alpha vitamin D alone, and control groups, respectively; P < 0.001). CONCLUSION: These findings suggest that the combined regimen could prevent postmenopausal bone loss.

Drug Therapy, Combination↗
PubMed1995

Cervical cytology and conservative management of cervical neoplasias during pregnancy.

To elucidate the clinical significance of cervical cytology during pregnancy, 7,725 pregnant women were examined. Abnormal cytologic findings were recorded in 65 cases (0.8%). Colposcopically directed punch biopsies revealed cervical dysplasia and carcinoma in 27 cases (0.35%). The incidences in a massive examination for 714,119 women in Osaka Prefecture were 1.1% and 0.25%, respectively. Cytologic findings of the patients with cervical neoplasia during pregnancy agreed well (76%) with their histologic findings. Colposcopically, the squamo-columnar junction was visible in many cases, and white epithelium was most commonly observed during pregnancy. Pre- and postpartum follow-up study revealed that progression from dysplasia was seen only in two (20%) of 20 cases. Laser conization was performed on six women during pregnancy, and four were microinvasive carcinoma, all of which underwent normal vaginal delivery without any complication from conization. These results suggest that routine cervical cytology must be performed during pregnancy, and cytologic and colposcopic diagnosis may supply enough data to avoid unnecessary biopsies. Moreover, laser conization is recommended as an excellent diagnostic and therapeutic procedure for women with microinvasive carcinoma during pregnancy.

Adolescent↗
PubMed1995

Endocrinological and histological changes after treatment of uterine leiomyomas with danazol or buserelin.

The following results were obtained from our investigations performed to compare the effects of danazol (400 mg/day orally for 4 to 6 months, n = 164) with those of buserelin (900 micrograms/day intranasally for 4 to 6 months, n = 83) on patients with uterine myomas. The effectiveness of buserelin (76.1%) in shrinking uterine myomas was better than that of danazol (56.7%). The serum-estradiol and progesterone levels were lower in the buserelin group than in the danazol group. The estrogen and progesterone receptors in a hysterectomied uterus were positively stained even at the end of those therapies. The degree and frequency of hyaline degeneration were higher in the buserelin group than in the danazol group. Thus, the shrinking of uterine myomas and the degree of hyaline degeneration might be caused by the lowering of uterine-tissue hormones, particularly of estradiol levels.

Adult↗
PubMed1995

The effect of unkei-to on pituitary gonadotropin secretion and ovulation in anovulatory cycles of young women.

Unkei-to (TJ-106) induced significant increases of plasma follicle stimulating hormone level in the first grade (P < 0.05), second grade amenorrhea without weight loss (P < 0.05), and weight loss related to second grade amenorrhea (P < 0.01) in eight weeks of treatment, respectively. Plasma estradiol level significantly increased 1.8 times in 4 week treatment with Unkei-to in first grade amenorrhea (P < 0.01). In second grade amenorrhea without weight loss and weight loss related second grade amenorrhea, plasma estradiol level significantly increased 2.9 times (P < 0.01) and 1.7 times (P < 0.05) in 8 weeks treatment, respectively. On the other hand, the patterns of pulsatile secretion of follicle stimulating hormone and luteinizing hormone remarkably improved by the treatment with Unkei-to. In the patients with second grade amenorrhea, follicles stimulating hormone and luteinizing hormone pulses appeared in 3 out of 13 (23.1%) and 6 out of 13 (46.2%) with the treatment of Unkei-to, respectively in 85% of whom no pulses has been observed before the treatment. Ovulation occurred in 62.2% (23/37), 26.6% (4/15), and 21.7% (5/23) of the patients with first grade, second grade amenorrhea without weight loss, and weight loss related second grade amenorrhea by the treatment with Unkei-to, respectively. These results indicate that Unkei-to is effective on improvement of gonadotropin pulsatile secretion in the treatment of anovulatory women. This suggests that Unkei-to may enhance the pituitary response to Gn-RH or improvement of the pulsatile secretion of Gn-RH, inducing normalization of diencephalon-pituitary-ovarian endocrine system in the anovulatory patients.

Adolescent↗
PubMed1995

Clinicopathological features of well-differentiated cervical adenocarcinoma with abundant mucus secretion.

Fourteen patients who had cervical adenocarcinoma with abundant mucus secretion (stages Ib: 4, IIb: 8, IIIb: 2) were reviewed. Their tumors were clearly distinguishable from the majority of cervical adenocarcinomas without abundant mucin on the basis of the clinicopathological features. The portio vaginalis featured large induration and swelling as well as showing rubber ball-like resilience. The surface of tumors showed no ulceration, necrosis, or bleeding, even in advanced cases. Colposcopy revealed large glandular openings filled with mucus. The initial smear test was negative or suspicious in 11 cases due to the abundance of mucus or slight cellular atypia. Even on biopsy findings, five cases were diagnosed as normal cervical glands. The diagnosis of cancer had been overlooked for six months to one year or more because of negative smears in six cases. The final histologic diagnosis was well-differentiated adenocarcinoma (endocervical type), including adenoma malignum and mucinous adenocarcinoma. Patients with this type of adenocarcinoma had a poor prognosis. It is important to keep in mind the distinctive clinical features of adenocarcinoma with abundant mucus secretion in order not to miss the diagnosis.

Adenocarcinoma↗
PubMed1995

[Effects of ulinastatin on postoperative renal function after cardiopulmonary bypass].

The effects of ulinastatin on postoperative renal function after the open cardiac surgery under cardiopulmonary bypass (CPB) were studied. N-acetyl-beta-D-glucosaminidase in urine as a marker of tubular function and serum creatinine rose significantly after CPB in the control group but not in the ulinastatin group. Ulinastatin was considered to be effective in protection of tubular function after CPB. In patient with poor preoperative renal function, ulinastatin prevented the deterioration of postoperative renal function by protecting tubular function.

Acute Kidney Injury↗
PubMed1995

[The support of postoperative renal function by ulinastatin in patients with preoperative renal dysfunction].

The principal perioperative management of patients with renal dysfunction is to prevent postoperative acute renal failure. Therefore, it is crucial to do all possible therapies by which its occurrence is prevented. We experienced three cases in which ulinastatin may have been beneficial to maintain postoperative renal function. The patients had preoperative renal dysfunction with serum Cr between 1.5 and 2.0 mg.dl-1. During the operation and for the three postoperative days, 300,000 units.day-1 of ulinastatin were administered intravenously. After the operation, serum Cr level was not elevated. Urine output and creatinine clearance increased. These three clinical cases suggest that ulinastatin may prevent the deterioration of postoperative renal function in patient with preoperative renal dysfunction.

Acute Kidney Injury↗
PubMed1995

Indications and options of nutritional treatment for Crohn's disease. A comparison of elemental and polymeric diets.

Several studies on enteral nutrition undertaken by our group led to the following findings: (1) A semielemental diet was as effective as an elemental diet in inducing remission. (2) A low-residue diet was useful for the maintenance of remission, with the effect depending upon the quantity given. (3) Intractability to enteral nutrition was found in patients with long-standing disease, in those with severe activity, and in those with colonic disease. Currently there is insufficient evidence to make specific recommendations for altering accepted indications for nutritional therapy.

Crohn Disease↗
PubMed1995

Detection of dihydrotestosterone (DHT) doping: alterations in the steroid profile and reference ranges for DHT and its 5 alpha-metabolites.

Dihydrotestosterone (DHT), a biologically active metabolite of testosterone, may be misused in sports to benefit from its anabolic and psychotropic effects. After DHT application, a significant increase of the glucuronides of DHT and its metabolites can be expected for a certain time period depending upon dose, formulation, route of administration, and in case of percutaneous administration the chainlength of the ester. DHT and its metabolites can be monitored by gas-chromatography/mass spectrometry (GC/MS) after enzymatic hydrolysis and trimethylsilylation. To investigate the extent of the alteration of the urinary steroid profile after DHT application, timely controlled experiments have been performed with: a) oral application of [16,16,17-2H3]-DHT, and b) sublingual application of a 25 mg dose of DHT. In the experiment with [16,16,17-2H3]-DHT within 24 hours about 44% of the applied dose was recovered after hydrolysis with beta-glucuronidase from E. coli as di- or tri-deuterated 5 alpha-androstane glucuronides: androsterone (33.2%), 5 alpha-androsta-ne-3 alpha,17 beta-diol (2.5%), 5 alpha-androstane-3 beta, 17 beta-diol (0.9%), DHT (7.2%). Hydrolysis with beta-glucuronidase/arylsulfatase from Helix Pomatia resulted in a about 10% higher yield except for DHT. In the study with sublingual application of 25 mg of DHT the extent of the recovery of DHT and its metabolites was in the same range as for the deuterated DHT. The urinary glucuronide concentrations of DHT, androsterone (AND), 5 alpha-androstane-3 alpha, 17 beta-diol (5 alpha A3 alpha D) and 5 alpha-androstane-3 beta,17 beta-diol (5 alpha A3 beta D) and their ratios to etiocholanolone (ETIO), 5 beta-androstane-3 alpha, 17 beta-diol (5 beta A3 alpha D) and epitestosterone (EPIT) were increased for up to 48 hours after application. For doping control purposes concentrations of DHT, 5 alpha A3 alpha D, 5 alpha A3 beta D and ratios of 5 alpha-metabolites to non 5 alpha-metabolites such as DHT/ETIO, DHT/EPIT, 5 alpha A3 alpha D/5 beta A3 alpha D, 5 alpha A3 beta D/5 beta A3 alpha D, and AND/ETIO outside the reference ranges are a proof for DHT application. Reference ranges for Asian and Caucasian male and female athletes are calculated from data bases of the Asian Games 1994, the previous Asian Games 1990 and the routine doping control samples of Caucasian athletes measured in Cologne 1994. At the occasion of the 1994 Asian Games in Hiroshima alterations in the concentrations and ratios of the DHT depending parameters for outside there reference ranges have been found and have been sanctioned on this basis by the Medical Commission of the Organisation of Olympic Council of Asia (OCA).

Adult↗